Position in NVS
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$3,602,992
+$305,731 QoQ
Shares Held
22,990
+6.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#321
of 1,603 holders
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kathmere Capital Management, LLC holds $38,480,404 across 14 Drug Manufacturers - General names. NVS ranks #4 (9.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
46,204 | $11,734,429 | |
| 2 | LLY |
ELI LILLY & Co
|
4,626 | $5,548,563 | |
| 3 | MRK |
Merck & Co., Inc.
|
30,944 | $3,976,304 | |
| 4 | NVS |
Novartis AG
This page
|
22,990 | $3,602,992 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
26,787 | $3,384,269 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
37,197 | $2,143,291 | |
| 7 | ABBV |
AbbVie Inc.
|
7,045 | $1,772,803 | |
| 8 | BIIB |
Biogen Inc.
|
7,285 | $1,573,997 |
All Filings in NVS
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,602,992 | 22,990 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $3,297,261 | 21,586 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $2,747,059 | 19,925 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $2,675,599 | 20,864 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $2,101,096 | 17,363 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $2,089,358 | 18,742 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $1,260,553 | 12,954 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $2,043,905 | 17,770 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1,459,992 | 13,714 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $1,207,093 | 12,479 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $1,127,632 | 11,168 | Shares | Sole | 2024-04-16 | |
| 2023-09-30 | $1,146,026 | 11,251 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $1,035,841 | 10,265 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $874,920 | 9,510 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $839,250 | 9,251 | Shares | Sole | 2023-01-24 | |
| 2022-06-30 | $353,504 | 4,182 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $284,661 | 3,244 | Shares | Sole | 2022-04-28 | |
| No filing history on record for this holder in this stock. | ||||||